Amgen Inc.

AMGN.BA·Buenos Aires·Healthcare

FollowCompareShare

23,310.00−80.00 (−0.34%)today

At close: Oct 16, 4:56 PM ART · May be delayed up to 20 min · ARS

1D5D1M6MYTD1Y5Y10Y20YAll

MountainLineCandles

Indicators

Prices may be delayed up to 20 min. Not investment advice. News volume: articles in the 4Search index each day.

Key statistics

Previous close23,390.00

Open23,580.00

Day range23,260.0023,640.00

52-week range12,320.0023,820.00

Off day high−1.40%

Off 52-week high−2.14%

Volume1.30K

Avg. volume (3M)3.07K

Market cap2.52T

EPS (TTM)112,568.33

Forward P/E—

P/E ratio (TTM)0.21

Dividend yield2.06% (479.97)

Beta (5Y)0.41

Shares outstanding108.13M

Short interest—

Earnings dateAug 4, 2025

Analyst target—

Profit margin22.95%

Related companies

Compare ›

Moves togetherAlso watched

The stocks whose daily moves over the past year went most closely with Amgen's: the correlation of their daily returns, where 1 would be moving as one.

Company	Mkt cap	Price	Today
MRKBMERCK & CO INC CEDEAR (5 REP 1MRK.BA · Correlation 0.52	11.65T	47,200.00	−0.13%
AZNBASTRAZENECA PLC CEDEAR EACH REPAZN.BA · Correlation 0.45	103.83T	66,950.00	−0.78%
COSTCostco Wholesale CorporationCOST.BA · Correlation 0.32	3.69T	33,300.00	+0.97%

What visitors to Amgen's page also look at.

Company	Mkt cap	Price	Today
MRKBMERCK & CO INC CEDEAR (5 REP 1MRK.BA	11.65T	47,200.00	−0.13%
TXNBTEXAS INSTRUMENTS INC CEDEAR EATXN.BA	16.36T	89,575.00	−0.58%
AZNBASTRAZENECA PLC CEDEAR EACH REPAZN.BA	103.83T	66,950.00	−0.78%
COSTCOSTCO WHOLESALE CORP CEDEAR EACOST.BA	3.69T	33,300.00	+0.97%
ADBEADOBE INC CEDEAR EACH 44 REP 1ADBE.BA	3.52T	9,035.00	−2.11%

From the 4Search instruments index: what each company does (its business description), its industry, size, headquarters and the markets it serves; and from a year of daily prices, which move together. Prices may be delayed up to 20 min.

Latest news

All AMGN.BA news ›

The Globe and Mail·7h agoPositive

Amgen (AMGN) Stock Is Up, What You Need To Know

Shares of biotech company Amgen (NASDAQ:AMGN) jumped 3.1% in the afternoon session after the company received a favorable court ruling that blocked a first-of-its-kind state price cap on its blockbuster drug, Enbrel. After the initial pop,…

markets.businessinsider.com·17h ago

Analysts’ Opinions Are Mixed on These Healthcare Stocks: Amgen (AMGN) and Collegium Pharmaceutical (COLL)

Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Amgen (AMGN) and Collegium Pharmaceutical (COLL). In a report released today, Mohit Bansal from Wells Fargo maintained a Hold rating on Amgen,…

Barchart.com·2d ago

Amgen's Q3 2026 Earnings: What to Expect

Barchart.com

Trefis·2d agoNegative

Is Amgen Stock Increasing Your Market Risk?

Investors holding shares of Amgen (AMGN), the $234 billion maker of drugs such as Repatha and Prolia, likely pair that position with broad exposure to the S&P 500. As the broader market rises and falls each day, the pharmaceutical stock’s…

Trefis·2d agoPositive

When Amgen’s Forecast And Chart Say The Same Thing, Pay Attention

Six drugs that management counts as its main growth drivers collectively grew 26% from a year earlier. They accounted for nearly 70% of product sales in the quarter ended June. Repatha, a cholesterol-lowering drug, grew 37% to $953…

csindie.com·2d agoPositive

As Amgen turns 25, the chatter is about who’s new on the list to the Kendall Square and Alewife party

The life sciences company Amgen celebrated Thursday in Kendall Square, marking a 25th anniversary in Cambridge’s innovation district – its 285,000-square-foot research center opened in 2001 – and company, local and state officials took the…

MarketBeat·1d agoPositive

Amgen Inc. $AMGN Stock: Frank Rimerman Advisors LLC Raises Holdings

The company also recently declared a quarterly dividend, which was paid on Friday, September 11th. Stockholders of record on Friday, August 21st were given a dividend of $2.52 per share. This represents a $10.08 dividend on an annualized…

MarketBeat·1d agoPositive

Amgen (NASDAQ:AMGN) Upgraded at Wall Street Zen

Amgen (NASDAQ:AMGN - Get Free Report) was upgraded by research analysts at Wall Street Zen from a "hold" rating to a "buy" rating in a research report issued to clients and investors on Sunday, Wall Street Zen reports. Check Out Our Latest…

MarketBeat·1d ago

Amgen Inc. $AMGN Stock Sold by TD Waterhouse Canada Inc.

Read Our Latest Stock Analysis on AMGN The firm also recently disclosed a quarterly dividend, which was paid on Friday, September 11th. Shareholders of record on Friday, August 21st were given a $2.52 dividend. The ex-dividend date was…

MarketBeat·1d ago

Amgen Inc. (NASDAQ:AMGN) Stock Has Average Price Target of $387.93

Check Out Our Latest Report on Amgen The company also recently declared a quarterly dividend, which was paid on Friday, September 11th. Shareholders of record on Friday, August 21st were issued a $2.52 dividend. This represents a $10.08…

From articles in the 4Search news index.

In the news

108mentions in 30 days

93with it in the headline

Positivesentiment

Mentioned with

Novartis75Eli Lilly47Pfizer43Biogen42Amgen Inc.41Johnson & Johnson37Vertex Pharmaceuticals29Jefferies27

People in the coverage

Otezla55Sjogren43Chris Lange38Danessa Lincoln38Robert38Tepezza38

Themes

Healthcare47Equities36All News and Stock Ideas35Pharmaceuticals35Biotech and Pharma Stock News33Earnings24Lly22Pharma19

Most coverage from

1. marketscreener.com19
2. marketbeat.com18
3. themarketsdaily.com8
4. trefis.com6
5. gurufocus.com4

Finance and business coverage in the 4Search news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 108 articles, not a forecast.

Market data is provided for information only and comes from free public sources. Prices may be delayed up to 15 minutes; data may be incomplete or inaccurate. Nothing on this page is investment advice or a recommendation to buy or sell any security. News and coverage analytics are drawn from the 4Search index. Terms of use.